Eloxx Pharmaceuticals, Inc.

WELLS FARGO & COMPANY/MN ELOX

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

46,703

Value ($000)

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	8	0.0%	46,703	9/30/2022
2022 Q2	8/12/2022	13	0.0%	46,706	6/30/2022
2022 Q1	5/16/2022	26	0.0%	46,672	3/31/2022
2021 Q4	2/14/2022	33	0.0%	46,670	12/31/2021
2021 Q3	11/15/2021	36	0.0%	21,370	9/30/2021
2021 Q2	8/16/2021	43	0.0%	21,455	6/30/2021
2021 Q1	5/13/2021	44	0.0%	13,098	3/31/2021
2020 Q4	2/9/2021	151	0.0%	37,814	12/31/2020
2020 Q3	11/5/2020	75	0.0%	28,824	9/30/2020
2020 Q2	8/13/2020	109	0.0%	35,968	6/30/2020
2020 Q1	5/14/2020	45	0.0%	22,983	3/31/2020
2019 Q4	2/14/2020	235	0.0%	31,920	12/31/2019